STOK: stoketherapeutics.com Cash per Share

Corporate emblem and logo of Stoke Therapeutics (STOK)

Demand for unique RNA therapy provides Stoke Therapeutics (STOK) with market priority and premium pricing power. The cash per share trend demonstrates current liquidity, where the 4.85 mark reflects the latest data. The success of the STK-001 drug supports the increase in share value, while maximum utilization of synthetic capacities ensures strict adherence to all clinical trial deadlines.

STOK: Stoke Cash per Share 07/04/2022 - 11/20/2026

Analytical breakdowns for Stoke Therapeutics

- market price and analyst price targets:
- cash position and cash flow details:
Comprehensive company analysis:Stoke Therapeutics
Signature product of Stoke Therapeutics, Inc.

Long-term risk control requires liquidity analysis via the ratio of free cash flow to the number of shares, which allows for the identification of fund reversal points and hidden costs. For Stoke Therapeutics (STOK), which focuses on therapies for rare genetic pathologies, the cash per share metric demonstrates the balance between funding biolabs and the risk of underinvesting in modernization, thereby determining the final investment profile.

Competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Cash Funds per Share BioLife Solutions BLFS|Wave Life Sciences (WVE) - Cash on Hand per Share|Maze Therapeutics, Inc. - Cash per Share|Cash Funds Calculated per Share Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Cash Funds per Share|TSHA: Cash Calculated per Single Share|Cash Funds per Share uniQure Pharma|MGTX - Cash Funds Volume per Share|Cash per Share RGNX|Cash Funds per Share SLDB (Solid Biosciences)|Ocugen Corp - Cash per Single Share|PACB: Cash Funds per Single Share|benitec.com - Cash per Share|DSGN - Cash per Share|RCKT: Cash per Share|FDMT (4D Molecular Therapeutics Inc) - Cash Funds per Share|Cash per Single Share LXEO|Cash Funds per Share KRRO|Cash per Share EDIT|SLN - Cash on Hand per Share|Cash per Share PRQR (ProQR)|CDXS - Cash per Single Share|Sangamo Therapeutics Inc. - Cash per Share|NAUT - Cash per Share|MGX: Cash per Share|Cash per Single Share Precision BioSciences, Inc.|GBIO (Generation Bio) - Cash per Share|Boundless Bio Inc. (BOLD) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology